Huang C C, Gerhardstein R P, Kim D Y, Hollister L
Medical College of Wisconsin.
Int Clin Psychopharmacol. 1987 Jan;2(1):69-75. doi: 10.1097/00004850-198701000-00006.
Double blind controlled study on fifty treatment-resistant schizophrenic inpatients showed a statistically significant improvement in favour of the high dose group.
一项针对50名难治性精神分裂症住院患者的双盲对照研究显示,高剂量组在统计学上有显著改善。